{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:41:41Z","timestamp":1781271701406,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ygyno.2015.03.057","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T08:31:44Z","timestamp":1428741104000},"page":"423-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The sooner the better: Genetic testing following ovarian cancer diagnosis"],"prefix":"10.1016","volume":"137","author":[{"given":"E.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"McCuaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Demsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Shuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chitayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Randall Armel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9999","key":"10.1016\/j.ygyno.2015.03.057_bb0015","article-title":"Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations","volume":"9999","author":"Narod","year":"2012","journal-title":"Clin. Genet."},{"issue":"12","key":"10.1016\/j.ygyno.2015.03.057_bb0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.057_bb0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"23","key":"10.1016\/j.ygyno.2015.03.057_bb0030","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2008.06.016","article-title":"What women with ovarian cancer think and know about genetic testing","volume":"111","author":"Lacour","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.03.057_bb0040","first-page":"767","article-title":"Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21","volume":"52","author":"Smith","year":"1993","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.02.017","article-title":"Hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.057_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2011.10.027","article-title":"BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia","volume":"124","author":"Rodriguez","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.057_bb0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0090-8258(03)00152-5","article-title":"Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel","volume":"89","author":"Hirsh-Yechezkel","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2015.03.057_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/AOG.0b013e31825f3576","article-title":"Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy","volume":"120","author":"Schrader","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.057_bb0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2013.05.003","article-title":"Keeping it simple: genetics referrals for all invasive serous ovarian cancers","volume":"130","author":"Demsky","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2011.09.040","article-title":"There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer","volume":"124","author":"Meiser","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2015.03.057_bb0080","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.057_bb0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2002.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"Ben David","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2015.03.057_bb0090","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian carcinoma","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2008.12.015","article-title":"BRCA1 and implications for response to chemotherapy in ovarian cancer","volume":"113","author":"Quinn","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2015.03.057_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/GIM.0b013e3181ab2295","article-title":"Timing of BRCA1\/BRCA2 genetic testing in women with ovarian cancer","volume":"11","author":"Daniels","year":"2009","journal-title":"Genet. Med."},{"issue":"19","key":"10.1016\/j.ygyno.2015.03.057_bb0105","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"7035","key":"10.1016\/j.ygyno.2015.03.057_bb0110","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.057_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2015.03.057_bb0120","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","article-title":"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer","volume":"366","author":"Ledermann","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2015.03.057_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/gyno.2000.5908","article-title":"Depression, anxiety, and quality of life in patients with epithelial ovarian cancer","volume":"78","author":"Bodurka-Bevers","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.057_bb0135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2004.07.028","article-title":"Prevalence and predictors of psychological distress among women with ovarian cancer","volume":"22","author":"Norton","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.03.057_bb0140","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/IGC.0b013e3182994365","article-title":"Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma","volume":"23","author":"Novetsky","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.057_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2015.03.057_bb0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG practice bulletin no. 103: hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.057_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2354.2005.00574.x","article-title":"Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40","volume":"14","author":"Ardern-Jones","year":"2005","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pec.2012.03.019","article-title":"Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact","volume":"89","author":"Wevers","year":"2012","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e31815f524f","article-title":"A systematic review of perceived risks, psychological and behavioral impacts of genetic testing","volume":"10","author":"Heshka","year":"2008","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.057_bb0170","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.1999.17.3.1040","article-title":"Attitudes, knowledge, and risk perceptions of women with breast and\/or ovarian cancer considering testing for BRCA1 and BRCA2","volume":"17","author":"Bluman","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.057_bb0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10897-014-9707-6","article-title":"Motivation to pursue genetic testing in individuals with a personal or family history of cardiac events or sudden cardiac death","volume":"23","author":"Erskine","year":"2014","journal-title":"J. Genet. Couns."},{"issue":"4 Pt 2","key":"10.1016\/j.ygyno.2015.03.057_bb0180","first-page":"353","article-title":"Intention to learn results of genetic testing for hereditary colon cancer","volume":"8","author":"Vernon","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"15","key":"10.1016\/j.ygyno.2015.03.057_bb0185","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2009.26.9589","article-title":"Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval","volume":"28","author":"Fong","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"9737","key":"10.1016\/j.ygyno.2015.03.057_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ygyno.2015.03.057_bb0195","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1470-2045(13)70240-7","article-title":"The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial","volume":"14","author":"Sandhu","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.057_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/annonc\/mdt384","article-title":"PARP inhibitors for BRCA1\/2 mutation-associated and BRCA-like malignancies","volume":"25","author":"Lee","year":"2014","journal-title":"Ann. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2017.02.021","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581500788X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581500788X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T16:26:08Z","timestamp":1537719968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581500788X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S009082581500788X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.057","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ygyno.2017.02.021","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sooner the better: Genetic testing following ovarian cancer diagnosis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}